From the scientist's bench
Press Releases, News, Events
Welcome to the BioCopy newsroom
March 29th, 2022
BioCopy AG presents ValidaTe
A novel ultra-fast screening technology to significantly speed up drug discovery in T-cell therapy
February 10th, 2022
Let's connect at Bio-Europe Spring
BioCopy will be partnering at Bio-Europe Spring, March 28-31, 2022. We are showcasing our unique technology for vaccine development and immunotherapy.
February 9th, 2022
BioCopy now a registered US trademark
This will strengthen our company’s prospects for the world's largest markets of biomedical innovation.
October 1st, 2021
Quick and easy determination of personal immune status against Covid-19
New biosensor developed by BioCopy and Freiburg University Clinic
July 7th, 2021
BioCopy AG and Immatics enter into collaboration
Characterization of T-cell receptor – peptide-HLA interactions
May 27th, 2021
Collaboration with Valneva
BioCopy technology enables further development of vaccines with regard to their effectiveness on a large number of variants.
March 30th, 2021
Working on a vaccine against African swine fever
BioCopy Holding AG and Institute of Virology and Immunology (IVI) announce collaboration on African swine fever